Freeport-McMoRan, AppLovin And A Major Healthcare Stock On CNBC's 'Final Trades'
Portfolio Pulse from Avi Kapoor
Joshua Brown highlighted AppLovin (APP) as the top-performing large-cap stock of the year, with its price target raised by Morgan Stanley. Stephanie Link recommended Freeport-McMoRan (FCX) due to China's recovery, supported by upgrades from BofA Securities and Scotiabank. Freeport-McMoRan is a major holding in the SPDR S&P Metals & Mining ETF (XME). Jim Lebenthal named CVS Health (CVS) ahead of its earnings report, with analysts expecting a decrease in earnings per share but an increase in revenue.
April 17, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
CVS Health's upcoming earnings report with expected revenue growth but lower EPS may have mixed impacts.
While the expected increase in revenue is positive, the anticipated decrease in earnings per share could temper investor enthusiasm, leading to a neutral short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 80
POSITIVE IMPACT
AppLovin's strong performance and raised price target by Morgan Stanley suggest positive momentum.
The upgrade in price target by a reputable analyst firm like Morgan Stanley typically signals strong confidence in the company's future performance, likely leading to increased investor interest.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Freeport-McMoRan's upgrades and its role in the recovery of China's market position it positively.
The upgrades from BofA Securities and Scotiabank, combined with China's economic recovery, suggest a favorable outlook for Freeport-McMoRan, potentially leading to stock appreciation.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
As Freeport-McMoRan is a top holding, XME may benefit from FCX's positive outlook.
Given Freeport-McMoRan's significant presence in XME, positive developments for FCX are likely to positively impact XME's performance as well.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70